Skip to: Content
Skip to: Site Navigation
Skip to: Search

October 13, 2008 3:38:52 PM CDT



Popular Cancer Drug Is Iffy and Expensive

Posted Jul 6, 08 10:48 AM CDT in Science & Health 

(Newser) – Avastin is one of the most widely prescribed cancer drugs in the world, but it might not work, the New York Times reports. The drug, made by Genentech, brings in about $2.3 billion a year in the US alone, but recent trials have shown that though the drug shrinks tumors in sufferers of colon, breast, and lung cancer, it offers little extension of life.

Further complicating the issue, Avastin is routinely prescribed for cancers for which it's not recommended. But some doctors can’t shake that humanitarian impulse, as Avastin patients have reported a positive quality-of-life change, Medicare dollars be damned. “I can’t say, ‘Let’s not use Avastin; it’s a very expensive drug and I am worried about the cost to society,’" said one physician.

Source New York Times

0 comments | Print E-mail | Digg Seed this on Newsvine Add this link to Del.icio.us StumbleUpon
The Genentech Inc. headquarters are seen in South San Francisco, Calif.   (AP Photo/Paul Sakuma, file)
Exterior view of Genentech Inc.   (AP Photo/Paul Sakuma)
Loaded boxes are seen in the stockroom of Swiss pharmaceutical company Roche.   (AP Photo/Keystone, Martin Ruetschi)
Medicine used in the treatment of advanced lung cancer.   (AP Photo/Javier Galeano)
« Prev« Prev | Next »Next » Slideshow
Our editors also recommend:

Threads (
1
 of 3)



Loading...

Premium Articles from HighBeam

Find more articles like this

Today's Most Popular

Loading...

Other Science & Health Stories


What is Newser?

2008 Codie Finalist

Newser gives you more news in less time. We search for the best and most important stories all over the web, read them for you, and deliver concise and sharp summaries—along with links to the full text. Newser provides a way to stay on top of an ever-expanding horizon of news and opinion—politics, sports, business, trends, technology, personalities, crimes, and controversies. Newser keeps you not just better informed, but, with our signature graphic interface and smart condensed format, more enjoyably informed.

Learn more »